For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Epidemiology and Biostatistics Dissertation Defense: Meghan Carey

Wednesday, August 7, 2024

10:00 AM-12:00 PM

Meghan Carey, MS, will present "Understanding follow-up care trajectories and quality for depression among Medicaid enrolled autistic young people."

Depression is a major contributor to disability. Autistic people are at higher risk for depression compared to the general population. Though autistic young people are frequent utilizers of health services, difficulties in communication for autistic young people, and their complex clinical presentation may further complicate providers’ ability to make mental health diagnoses and therefore delay condition management. Depression tends to arise during adolescence or early adulthood, a developmental period that sets the stage for outcomes later in adulthood. Outcomes among autistic adults are poor in the domains of physical and mental health, independence, employment, social engagement, even compared to peers with other developmental or intellectual disabilities. In line with the multiple minority theory, studies of depression suggest prevalence may be higher among already vulnerable groups. Females, marginalized racial and ethnic groups, and individuals with co-occurring ID have established delays in diagnosis for autism, and may be at increased risk for delays in depression diagnosis. Understanding the follow-up care and quality of these conditions matters because better management of conditions can have positive downstream effects on morbidity and mortality, such as the increased suicide rate among autistic people.

The dissertation followed >1.8 million Medicaid enrollees ages 8-29 through their initial diagnoses of depression and subsequent treatment for it. Aim 1 of this project describes the prevalence, incidence, and profiles of treated depression among Medicaid-enrolled autistic young people. Aim 2 identified group-based trajectories of treatment following a new major depressive episode. Aim 3 investigated the quality and predictors of follow-up care received following ED visits and hospitalization for depression using established healthcare quality measures. All study aims examined differences in findings by diagnostic subgroups, with a particular focus on autistic people, and important subgroups within the autistic community: females, marginalized racial and ethnic groups, and individuals with co-occurring ID. This project has multiple short- and long-term impacts on the autistic community, such as in the short-term pointing toward improvements in the quality of follow-up care received after ED visits or hospitalizations related to depression, which could reduce readmissions and risk of suicide. In the long-term, study results can guide Medicaid resource allocation and planning for future programmatic enrollment needs as well as support the ability of the Medicaid program to make available the services that the autistic community need for depression.

Meghan is a PhD candidate in Epidemiology working under the supervision of Dr. Kristen Lyall. Her research is broadly focused on the systemic factors that influence healthcare delivery and outcomes for autistic individuals.

Dissertation committee members: Kristen Lyall (chair), ScD, Lindsay Shea, DrPH, Brian Lee, PhD, Diana Schendel, PhD, Laura Graham Holmes, PhD.

Zoom link

Contact Information

Nancy Colon-Anderson
nanderson@drexel.edu

Remind me about this event. Notify me if this event changes. Add this event to my personal calendar.

Location

Zoom

Audience

  • Undergraduate Students
  • Graduate Students
  • Faculty
  • Staff
  • Alumni
  • Parents & Families